全文获取类型
收费全文 | 2292篇 |
免费 | 105篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 44篇 |
妇产科学 | 156篇 |
基础医学 | 239篇 |
口腔科学 | 16篇 |
临床医学 | 143篇 |
内科学 | 638篇 |
皮肤病学 | 46篇 |
神经病学 | 230篇 |
特种医学 | 78篇 |
外科学 | 301篇 |
综合类 | 8篇 |
预防医学 | 91篇 |
眼科学 | 42篇 |
药学 | 124篇 |
中国医学 | 6篇 |
肿瘤学 | 247篇 |
出版年
2023年 | 18篇 |
2022年 | 51篇 |
2021年 | 56篇 |
2020年 | 29篇 |
2019年 | 44篇 |
2018年 | 56篇 |
2017年 | 47篇 |
2016年 | 58篇 |
2015年 | 56篇 |
2014年 | 103篇 |
2013年 | 108篇 |
2012年 | 178篇 |
2011年 | 146篇 |
2010年 | 89篇 |
2009年 | 78篇 |
2008年 | 157篇 |
2007年 | 146篇 |
2006年 | 165篇 |
2005年 | 135篇 |
2004年 | 148篇 |
2003年 | 113篇 |
2002年 | 87篇 |
2001年 | 26篇 |
2000年 | 21篇 |
1999年 | 30篇 |
1998年 | 45篇 |
1997年 | 22篇 |
1996年 | 22篇 |
1995年 | 16篇 |
1994年 | 22篇 |
1993年 | 6篇 |
1992年 | 12篇 |
1991年 | 16篇 |
1990年 | 6篇 |
1989年 | 8篇 |
1988年 | 10篇 |
1987年 | 5篇 |
1986年 | 7篇 |
1985年 | 12篇 |
1984年 | 7篇 |
1983年 | 5篇 |
1982年 | 4篇 |
1980年 | 3篇 |
1974年 | 3篇 |
1973年 | 2篇 |
1972年 | 2篇 |
1969年 | 6篇 |
1968年 | 6篇 |
1966年 | 5篇 |
1965年 | 9篇 |
排序方式: 共有2415条查询结果,搜索用时 31 毫秒
101.
Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar
下载免费PDF全文
![点击此处可从《Catheterization and cardiovascular interventions》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Jean‐Pierre Déry MD MHS Kenneth W. Mahaffey MD Pierluigi Tricoci MD PhD Harvey D. White DSC Mohua Podder PhD Cynthia M. Westerhout PhD David J. Moliterno MD Robert A. Harrington MD Edmond Chen MD John Strony MD Frans Van de Werf MD Khaled M. Ziada MD Claes Held MD PhD Philip E. Aylward MD Paul W. Armstrong MD Sunil V. Rao MD 《Catheterization and cardiovascular interventions》2016,88(2):163-173
102.
103.
Anna Tisselli Pierluigi Pieri Giovanni Moscatelli Monica Agostini Oriana Nanni Aureliano Spinelli Pietro Riva 《Journal of nuclear cardiology》1997,4(3):195-201
Background
The presence of defects at stress-redistribution thallium-201 scintigraphy is related to a higher risk of cardiac events. However, the prognostic value of defects that become reversible after reinjection is not known. In this study we evaluated the prognostic contribution of stress-redistribution-reinjection with special regard to 3-hour fixed defects that become reversible after reinjection.Methods and Results
We studied 122 patients with chronic myocardial infarction (>2 months) and suspected or known residual ischemia, with stress-redistribution-reinjection planar scintigraphy. Thallium scans were analyzed by three observers (three segments per view, 5-point score) and classified as normal, fixed, and reversible. The lung/heart ratio was also calculated. At a median follow-up of 47 months, 10 patients had hard events (four deaths and six myocardial infarctions) (group I), 12 patients had unstable angina (group II), 12 patients underwent planned coronary artery bypass grafting or percutaneous transluminal coronary angioplasty (group III), and 86 patients had no events (group IV). The presence of fixed defects that became reversible after reinjection did not identify patients at higher risk. The number of reversible defects at 3 hours was significantly higher only in patients who underwent revascularization. Unstable angina was not predicted by any scintigraphic pattern. The variables that were statistically related to hard events by univariate analysis were increased lung uptake, reversible cavity dilation, and the number of fixed defects that remained fixed after reinjection. By Cox multivariate analysis, the strongest predictor of hard events was the presence of more than three fixed defects that remained fixed after reinjection as a marker of irreversible myocardial damage.Conclusions
201TI reinjection is a useful approach for not only detecting viable myocardium but also risk stratification in patients with chronic myocardial infarction. 相似文献104.
Hartel M Di Mola FF Gardini A Zimmermann A Di Sebastiano P Guweidhi A Innocenti P Giese T Giese N Büchler MW Friess H 《World journal of surgery》2004,28(8):818-825
Connective tissue growth factor (CTGF), which is regulated by transforming growth factor-ß (TGFß), has recently been implicated in the pathogenesis of fibrotic diseases and tumor stroma. Inasmuch as generation of desmoplastic tissue is characteristic for pancreatic cancer, it is not known whether it gives pancreatic cancer cells a growth advantage or is a reaction of the body to inhibit cancer cell progression. In the present study we analyzed the expression and localization of CTGF and evaluated whether it influences the prognosis of pancreas cancer. Tissue samples were obtained from 25 individuals (6 women, 19 men) undergoing pancreatic resection for pancreatic cancer. Tissue samples from 13 previously healthy organ donors (5 women, 8 men) served as controls. Expression of CTGF was studied by Northern blot analysis. In situ hybridization and immunohistochemistry localized the respective mRNA moieties and proteins in the tissue samples. Northern blot analysis revealed that pancreatic cancer tissue samples exhibited a 46-fold increase in CTGF mRNA expression (p < 0.001) over that of normal controls. In vitro studies confirmed that pancreatic stellate cells are the major source of CTGF mRNA expression and revealed a large variance in basal and TGFß-induced CTGF expression in cultured pancreatic cancer cells. This could also be confirmed by in situ hybridization, indicating that CTGF mRNA signals were located principally in fibroblasts, with only weak signals in the cancer cells. High CTGF mRNA levels in the tissue samples correlated with better tumor differentiation (p < 0.03). In addition, patients whose tumors exhibited high CTGF mRNA levels (> onefold increase above normal controls) lived significantly longer than those whose tumors expressed low CTGF mRNA levels (none to onefold) (p < 0.04 multivariate analysis). Our present data indicate that CTGF, as a downstream mediator of TGFß, is overexpressed in connective tissue cells and to a lesser extent in pancreatic cancer cells. Because patients with high CTGF mRNA expression levels have a better prognosis, our findings indicate that the desmoplastic reaction provides a growth disadvantage for pancreatic cancer cells. 相似文献
105.
106.
107.
Viola Guardigni Valeria Cento Stefano Ianniruberto Lorenzo Badia Marianna Aragri Matteo Conti Carlo Federico Perno Pierluigi Viale Francesca Ceccherini-Silberstein Gabriella Verucchi 《Infection》2018,46(5):717-720
Direct-acting antivirals (DAAs) for the treatment of HCV have dramatically increased the rate of sustained virological response: patients not achieving sustained virological response represent a challenge and rates of late recurrent viremia are very low. We describe here the first case of a very late HCV relapse, following an atypical kinetics (characterized by a spontaneous but transient HCV clearance after an early virological relapse), in a HIV co-infected patient treated with DAAs. Optimal adherence to the therapy was well documented and a phylogenetic analysis ruled out a possible reinfection from a different HCV strain. In conclusion, our case underlines the importance of a long follow-up (>?48 weeks) after DAAs therapies in HCV–HIV co-infected patients who might benefit the most from a very rigorous virological surveillance. 相似文献
108.
109.
Giovanni Francesco MARANGI Pierluigi GIGLIOFIORITO Vito TOTO Marika LANGELLA Tiziano PALLARA Paolo PERSICHETTI 《The Journal of dermatology》2010,37(5):488-492
Embolia cutis medicamentosa, also known as Nicolau’s syndrome, is a rare complication due to i.m. injections. Its real incidence is actually underestimated. Many drugs have been associated with it, but at the time only a few studies showed a related pathogenetic mechanism. Symptoms consist of immediate local pain, edema and cutaneous, subcutaneous and even muscular necrosis occurring in the first 48 h. The type of treatment depends mostly on time of diagnosis. A medical resolution can be achieved through heparin and cortisone injections within the first 48 h. Surgical debridement has to be considered as the main treatment in case of late diagnosis. We present three cases of Nicolau’s syndrome presenting to us in a short period of time that we treated with surgical debridement. 相似文献
110.
Analysis of 138 consecutive ovarian cancer patients: Incidence and characteristics of familial cases 总被引:2,自引:0,他引:2
Stefano Greggi Maurizio Genuardi Pierluigi Benedetti-Panici Rosa Cento Giovanni Scambia Giovanni Neri Salvatore Mancuso 《Gynecologic oncology》1990,39(3):300-304
Eight families with two or more first-degree relatives affected with ovarian carcinoma were identified among a series of 138 consecutive ovarian cancer patients. History of breast cancer was reported in six of the eight families. Five of 19 patients with familial cancer developed ovarian cancer as a second primary tumor following breast carcinoma, whereas only 6/130 sporadic cases had a previous history of breast cancer. No significant difference was detected in clinical and pathological features between sporadic and familial cases. However, in three high-risk families ovarian cancer tended to develop at a younger age compared with other familial cases and with sporadic occurrences, and nulliparity was less frequent in the familial group. These observations emphasize the need to take into account multiple factors-in addition to positive family history-for the evaluation of genetic predisposition to ovarian carcinoma. 相似文献